Treatment of the Pimples and Bumps of Rosacea From
For nearly 20 years, the only FDA-approved oral treatment for rosacea was Oracea® (doxycycline, 40 mg). But with once-daily EMROSI™, there's finally a better option.
In studies, EMROSI™ was proven superior to Oracea® for treating the pimples and bumps of rosacea, with a safety profile that's similar to placebo.
Clinical Study Results
of patients had clear or almost clear skin on EMROSI™ vs 39% on Oracea® after 16 weeks of treatment
% of Patients With Clear or Almost Clear Skin at Week 16
Pooled Phase 3 Clinical Trial Data
Clinical Study Results
fewer pimples and bumps for patients on EMROSI™
vs -14.8 fewer on Oracea® after 16 weeks of treatment*
Reduction of Pimples & Bumps of Rosacea at Week 16
Pooled Phase 3 Clinical Trial Data
*The average patient in the clinical trial started with 25 pimples and bumps of rosacea.
Study design: Two identically designed, randomized, double-blind, active- and placebo-controlled Phase 3 trials, including 653 total participants, to compare the impact of oral EMROSI™, Oracea®, and placebo as standalone treatments in adults with rosacea.
EMROSI™ demonstrated a safety profile similar to placebo. The frequency of side effects was low, and most were reported as mild or moderate.
See Safety DataEMROSI is a prescription medicine used to treat adults with pimples and bumps (inflammatory lesions) caused by a condition called rosacea.
EMROSI should not be used for the treatment of infections. It is not known if EMROSI is safe and effective in children.
EMROSI is an extended-release capsule that contains minocycline, a tetracycline medicine. Tetracyclines, when taken by mouth, may cause serious side effects, including: serious skin or allergic reactions which can cause skin redness, rash, hives, sores in your mouth, or your skin blisters and peels; swelling of your face, eyes, lips, tongue, or throat; trouble swallowing or breathing; blood in your urine; fever, yellowing of the skin or the whites of your eyes (jaundice), dark colored urine; pain on the right side of the stomach area (abdominal pain); chest pain or abnormal heartbeats; swelling in your legs, ankles, and feet; diarrhea which may be caused by an infection that can cause watery or bloody stools; loss of appetite; tiredness; unexplained bleeding or bleeding more easily than normal; confusion; sleepiness; vision changes, including blurred vision, double vision, or permanent vision loss; unusual headaches; fever; rash; joint pain; body weakness. Call your doctor right away if these side effects occur.
The most common side effects of EMROSI include stomach upset or burning (dyspepsia) after eating or drinking.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088. You may also report side effects to Journey Medical Corporation at 1‑855‑531‑1859.
Please see full Prescribing Information, including Patient Product Information.